局部-话题@MedSci

#局部#

598篇内容 | 6400人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1406113, encodeId=0d8214061135d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, objectType=article, longId=219626, objectId=89d3219626c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d3219626c9, replyNumber=0, likeNumber=33, createdTime=2021-11-03, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d3219626c9, moduleTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d3219626c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406112, encodeId=efbf1406112b1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=科幻！ACS NANO:纳米机器人用于肿瘤细胞局部治疗, objectType=article, longId=219210, objectId=ece8219210e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ece8219210e0, replyNumber=0, likeNumber=104, createdTime=2021-10-26, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ece8219210e0, moduleTitle=科幻！ACS NANO:纳米机器人用于肿瘤细胞局部治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ece8219210e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406111, encodeId=17c014061116c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=JEADV:新型固定剂量钙泊三烯和倍他米松乳膏局部治疗斑块型银屑病的疗效和安全性, objectType=article, longId=219036, objectId=1886219036cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1886219036cf, replyNumber=0, likeNumber=141, createdTime=2021-10-23, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1886219036cf, moduleTitle=JEADV:新型固定剂量钙泊三烯和倍他米松乳膏局部治疗斑块型银屑病的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1886219036cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406110, encodeId=0a14140611092, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=10年中国女性数据：哪些早期乳腺癌保乳手术患者，更易局部复发？, objectType=article, longId=218942, objectId=6e5c218942cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e5c218942cb, replyNumber=0, likeNumber=115, createdTime=2021-10-22, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e5c218942cb, moduleTitle=10年中国女性数据：哪些早期乳腺癌保乳手术患者，更易局部复发？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e5c218942cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406109, encodeId=d6b614061098b, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Eur Acad Dermatol Venereol：局部使用Thiamidol VS. 4%氢醌霜治疗面部黄褐斑的疗效和安全性, objectType=article, longId=218777, objectId=cb5a218e773e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb5a218e773e, replyNumber=0, likeNumber=138, createdTime=2021-10-19, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb5a218e773e, moduleTitle=J Eur Acad Dermatol Venereol：局部使用Thiamidol VS. 4%氢醌霜治疗面部黄褐斑的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb5a218e773e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406108, encodeId=07d01406108e1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, objectType=article, longId=218658, objectId=c75f218658a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75f218658a9, replyNumber=0, likeNumber=111, createdTime=2021-10-17, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75f218658a9, moduleTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75f218658a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406107, encodeId=0b8c140610eed, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol：局部复发乳腺癌患者的危险因素以及手术治疗效果, objectType=article, longId=218644, objectId=3b44218644e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b44218644e0, replyNumber=0, likeNumber=113, createdTime=2021-10-17, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b44218644e0, moduleTitle=Front Oncol：局部复发乳腺癌患者的危险因素以及手术治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b44218644e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406106, encodeId=7dde140610624, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol：局部晚期鼻咽癌三种诱导化疗的疗效和毒性：10年随访结果, objectType=article, longId=218614, objectId=3d32218614c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d32218614c3, replyNumber=0, likeNumber=120, createdTime=2021-10-16, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d32218614c3, moduleTitle=Front Oncol：局部晚期鼻咽癌三种诱导化疗的疗效和毒性：10年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d32218614c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406105, encodeId=b7cf140610512, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur Urol：局部前列腺癌治疗中，开放式根治性前列腺切除术与机器人辅助腹腔镜前列腺切除术哪个好？, objectType=article, longId=218607, objectId=2a4421860e8f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a4421860e8f, replyNumber=0, likeNumber=89, createdTime=2021-10-16, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a4421860e8f, moduleTitle=Eur Urol：局部前列腺癌治疗中，开放式根治性前列腺切除术与机器人辅助腹腔镜前列腺切除术哪个好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a4421860e8f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406104, encodeId=345014061046a, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol：术前放疗(RT)和治疗前CEA水平跟局部晚期直肠癌（LARC）患者预后的关系, objectType=article, longId=218486, objectId=f89c21848669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f89c21848669, replyNumber=0, likeNumber=73, createdTime=2021-10-14, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f89c21848669, moduleTitle=Front Oncol：术前放疗(RT)和治疗前CEA水平跟局部晚期直肠癌（LARC）患者预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f89c21848669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406103, encodeId=a1911406103b2, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=16张精美图片：局部晚期非小细胞肺癌放疗靶区勾画, objectType=article, longId=218469, objectId=dbaf21846903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbaf21846903, replyNumber=0, likeNumber=103, createdTime=2021-10-14, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbaf21846903, moduleTitle=16张精美图片：局部晚期非小细胞肺癌放疗靶区勾画, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbaf21846903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406102, encodeId=b4431406102b0, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=今晚7点直播 | 不可手术局部晚期非小细胞肺癌的靶区勾画, objectType=article, longId=218426, objectId=70c521842614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70c521842614, replyNumber=0, likeNumber=65, createdTime=2021-10-13, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70c521842614, moduleTitle=今晚7点直播 | 不可手术局部晚期非小细胞肺癌的靶区勾画, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70c521842614)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406101, encodeId=86c4140610133, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=A&R：具有组织学和临床相关性的青少年局部硬皮病皮肤的转录组学评价, objectType=article, longId=218308, objectId=79022183081d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79022183081d, replyNumber=0, likeNumber=116, createdTime=2021-10-11, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79022183081d, moduleTitle=A&R：具有组织学和临床相关性的青少年局部硬皮病皮肤的转录组学评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79022183081d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406100, encodeId=d20514061003b, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性, objectType=article, longId=218067, objectId=2f5021806e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f5021806e4d, replyNumber=0, likeNumber=99, createdTime=2021-10-04, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f5021806e4d, moduleTitle=Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f5021806e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406099, encodeId=aa481406099f6, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Science：局部重编程让心肌细胞“返老还童” 让心脏实现再生！, objectType=article, longId=217826, objectId=1c1a21e82638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1a21e82638, replyNumber=0, likeNumber=97, createdTime=2021-09-30, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1a21e82638, moduleTitle=Science：局部重编程让心肌细胞“返老还童” 让心脏实现再生！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1a21e82638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406098, encodeId=cd861406098d0, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Cancers：帕妥珠单抗和曲妥珠单抗联合局部放疗治疗HER2阳性乳腺癌患者的疗效和安全性, objectType=article, longId=217767, objectId=989c21e7670d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=989c21e7670d, replyNumber=0, likeNumber=75, createdTime=2021-09-29, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=989c21e7670d, moduleTitle=Cancers：帕妥珠单抗和曲妥珠单抗联合局部放疗治疗HER2阳性乳腺癌患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=989c21e7670d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406097, encodeId=8ed5140609ec2, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性, objectType=article, longId=217734, objectId=763321e734eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763321e734eb, replyNumber=0, likeNumber=83, createdTime=2021-09-28, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763321e734eb, moduleTitle=JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763321e734eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406096, encodeId=bceb14060961b, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=EU：局部治疗对男性原发性小细胞前列腺癌的影响, objectType=article, longId=217669, objectId=d6d321e66900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d321e66900, replyNumber=0, likeNumber=74, createdTime=2021-09-27, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d321e66900, moduleTitle=EU：局部治疗对男性原发性小细胞前列腺癌的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6d321e66900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406095, encodeId=d8af1406095d7, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据, objectType=article, longId=217450, objectId=f9a121e450ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9a121e450ea, replyNumber=0, likeNumber=117, createdTime=2021-09-24, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9a121e450ea, moduleTitle=Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9a121e450ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406094, encodeId=03b914060948a, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Gynecol Oncol：鳞状细胞癌抗原（SCC-Ag）是局部晚期宫颈癌患者的生存预后因素, objectType=article, longId=217443, objectId=bacd21e4438e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bacd21e4438e, replyNumber=0, likeNumber=97, createdTime=2021-09-24, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bacd21e4438e, moduleTitle=Gynecol Oncol：鳞状细胞癌抗原（SCC-Ag）是局部晚期宫颈癌患者的生存预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bacd21e4438e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部

2020-05-29

chg122 (审核中...)

前往app查看评论内容

#局部#

Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究

2021-11-03

chg122 (审核中...)

前往app查看评论内容

#局部#

科幻！ACS NANO:纳米机器人用于肿瘤细胞局部治疗

2021-10-26

chg122 (审核中...)

前往app查看评论内容

#局部#

JEADV:新型固定剂量钙泊三烯和倍他米松乳膏局部治疗斑块型银屑病的疗效和安全性

2021-10-23

chg122 (审核中...)

前往app查看评论内容

#局部#

10年中国女性数据：哪些早期乳腺癌保乳手术患者，更易局部复发？

2021-10-22

chg122 (审核中...)

前往app查看评论内容

#局部#

J Eur Acad Dermatol Venereol：局部使用Thiamidol VS. 4%氢醌霜治疗面部黄褐斑的疗效和安全性

2021-10-19

chg122 (审核中...)

前往app查看评论内容

#局部#

Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药

2021-10-17

chg122 (审核中...)

前往app查看评论内容

#局部#

Front Oncol：局部复发乳腺癌患者的危险因素以及手术治疗效果

2021-10-17

chg122 (审核中...)

前往app查看评论内容

#局部#

Front Oncol：局部晚期鼻咽癌三种诱导化疗的疗效和毒性：10年随访结果

2021-10-16

chg122 (审核中...)

前往app查看评论内容

#局部#

Eur Urol：局部前列腺癌治疗中，开放式根治性前列腺切除术与机器人辅助腹腔镜前列腺切除术哪个好？

2021-10-16

智慧医人 (审核中...)

前往app查看评论内容

#局部#

Front Oncol：术前放疗(RT)和治疗前CEA水平跟局部晚期直肠癌（LARC）患者预后的关系

2021-10-14

chg122 (审核中...)

前往app查看评论内容

#局部#

16张精美图片：局部晚期非小细胞肺癌放疗靶区勾画

2021-10-14

chg122 (审核中...)

前往app查看评论内容

#局部#

今晚7点直播 | 不可手术局部晚期非小细胞肺癌的靶区勾画

2021-10-13

chg122 (审核中...)

前往app查看评论内容

#局部#

A&R：具有组织学和临床相关性的青少年局部硬皮病皮肤的转录组学评价

2021-10-11

chg122 (审核中...)

前往app查看评论内容

#局部#

Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性

2021-10-04

chg122 (审核中...)

前往app查看评论内容

#局部#

Science：局部重编程让心肌细胞“返老还童” 让心脏实现再生！

2021-09-30

chg122 (审核中...)

前往app查看评论内容

#局部#

Cancers：帕妥珠单抗和曲妥珠单抗联合局部放疗治疗HER2阳性乳腺癌患者的疗效和安全性

2021-09-29

chg122 (审核中...)

前往app查看评论内容

#局部#

JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性

2021-09-28

chg122 (审核中...)

前往app查看评论内容

#局部#

EU：局部治疗对男性原发性小细胞前列腺癌的影响

2021-09-27

chg122 (审核中...)

前往app查看评论内容

#局部#

Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据

2021-09-24

chg122 (审核中...)

前往app查看评论内容

#局部#

Gynecol Oncol：鳞状细胞癌抗原（SCC-Ag）是局部晚期宫颈癌患者的生存预后因素

2021-09-24

科室
- - 订阅+
  - 更多科室
工具
服务